Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
4 Patents
#30 in
#413 in Norway
Inovio as
Forward Citations = 141
7 inventors:
Inovio as
CIPO Patents = 2
Forward Citations = 141
Loading Chart...
Loading Chart...
7 inventors (with patents filed for the assignee):
Iacob Mathiesen (4 out of 14 patents)
Torunn E Tjelle (2 out of 5 patents)
Knut Arvid Sorensen Rekdahl (1 out of 2 patents)
4. Bjorn David-Andersen (1 out of 2 patents)
5. Terje Lomo (1 out of 3 patents)
6. Knut Arvid Sørensen Rekdahl (1 out of 1 patent)
7. Bjøm David-Andersen (1 out of 1 patent)
8. Knut Arvid Rekdahl (0 patent)
9. Torunn Elisabeth Tjelle (0 patent)
4 patents:
Company Overview
Inovio is a biotechnology company focused on developing DNA-based immunotherapies and vaccines to prevent and treat infectious diseases and cancers. Their proprietary platform enables the delivery of DNA directly into cells, stimulating a targeted immune response. Inovio is dedicated to advancing innovative treatments with the potential to transform the way diseases are prevented and treated.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Inovio as. Retrieved from https://idiyas.com/company/inovio-as
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]